
The majority of samples in existing zzso zzso are surgical specimens of primary zzso zzso into zzso biology, such as zzso zzso zzso zzso and the evolution of the disease during therapy, require zzso from the primary zzso and those that reflect the patient's disease in specific zzso zzso zzso technologies facilitate deep interrogation of zzso but the characteristics of the samples can determine the ultimate accuracy of the zzso The challenge is to biopsy zzso in some cases serially over time, ensuring that the samples are zzso viable, and adequate both in quantity and quality for subsequent molecular zzso The collection of next-generation zzso zzso and blood samples at defined time points during the disease zzso for discovery research or to guide clinical zzso additional challenges and zzso From an organizational perspective, it also requires new additions to the multidisciplinary therapeutic team, notably zzso zzso molecular zzso and zzso In this Review, we describe the existing procedures for sample procurement and processing of next-generation zzso and highlight the issues involved in this zzso including the ethical, zzso scientific, zzso and financial challenges accompanying next-generation zzso 

